Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025)

Aurora Cannabis (ACB) posted quarterly Non-Current Deferred Tax Liability of $2.5 million for Q4 2025, up 269.28% year-on-year from $675761.6 in Q4 2024, and down 1.37% on a QoQ basis from $2.5 million in Q3 2025.

Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Non-Current Deferred Tax Liability for 8 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 269.28% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 million (up 269.28% YoY) and the FY2025 annual result came in at $1.4 million, up 1194.95% from the prior year.
  • Non-Current Deferred Tax Liability fell to $2.5 million in Q4 2025 per ACB's latest filing, from $2.5 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for ACB reached as high as $30.5 million in Q1 2023 and fell as low as $105380.1 in Q1 2024.
  • A 5-year average of $9.5 million and a median of $11.4 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability sank 99.65% — and 2025, when it surged 1154.55%.
  • Year by year, Non-Current Deferred Tax Liability stood at $24.1 million in 2021, then sank by 49.93% to $12.1 million in 2022, then slipped by 0.62% to $12.0 million in 2023, then sank by 94.37% to $675761.6 in 2024, then surged by 269.28% to $2.5 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $2.5 million, $2.5 million, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.50 Mn
Dec 31, 2025 2.50 Mn
Sep 30, 2025 2.53 Mn
Sep 30, 2025 2.53 Mn
Jun 30, 2025 1.38 Mn
Jun 30, 2025 1.38 Mn
Mar 31, 2025 1.32 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 675,761.59
Dec 31, 2024 675,761.59
Sep 30, 2024 11.37 Mn
Sep 30, 2024 11.37 Mn
Jun 30, 2024 12.86 Mn
Jun 30, 2024 12.86 Mn
Mar 31, 2024 105,380.08
Mar 31, 2024 105,380.08
Dec 31, 2023 11.99 Mn
Dec 31, 2023 11.99 Mn
Sep 30, 2023 12.36 Mn
Sep 30, 2023 12.36 Mn